Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Bero

Showing results (181-190 of 206) with videos related to

Pageof 21
Sort By:
Device|December 1, 2025
Ethical, legal, and social issues related to ingestible, implantable electronic devices and mRNA delivery devicesLisa Bero, Natalie Banacos, Christine M Baugh, et al.
BMJ Open|May 14, 2020
Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional studyKimberly Turner, Andrea Carboni-Jiménez, Carla Benea, et al.
American Journal of Public Health|November 8, 2023
Health Effects of High-Concentration Cannabis Products: Scoping Review and Evidence MapLisa Bero, Rosa Lawrence, Jean-Pierre Oberste, et al.
Journal of Clinical Epidemiology|January 26, 2015
World Health Organization strong recommendations based on low-quality evidence (study quality) are frequent and often inconsistent with GRADE guidancePaul E Alexander, Juan P Brito, Ignacio Neumann, et al.
Environment International|May 9, 2016
Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosanPaula I Johnson, Erica Koustas, Hanna M Vesterinen, et al.
BMJ (Clinical Research Ed.)|October 14, 2021
Conduct and reporting of formula milk trials: systematic reviewBartosz Helfer, Jo Leonardi-Bee, Alexandra Mundell, et al.
Annals of Internal Medicine|July 15, 2024
Development and Evaluation of a Framework for Identifying and Addressing Spin for Harms in Systematic Reviews of InterventionsRiaz Qureshi, Kevin Naaman, Nicolas G Quan, et al.
Journal of Clinical Epidemiology|September 25, 2015
A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidancePaul E Alexander, Michael R Gionfriddo, Shelly-Anne Li, et al.
The Cochrane Database of Systematic Reviews|December 7, 2019
Cochrane Sustainable Healthcare: evidence for action on too much medicineMinna Johansson, Lisa Bero, Xavier Bonfill, et al.
BMJ (Clinical Research Ed.)|December 5, 2019
Pathways to independence: towards producing and using trustworthy evidenceRay Moynihan, Lisa Bero, Sue Hill, et al.
Pageof 21

Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
Device|December 1, 2025
Ethical, legal, and social issues related to ingestible, implantable electronic devices and mRNA delivery devicesLisa Bero, Natalie Banacos, Christine M Baugh, et al.
BMJ Open|May 14, 2020
Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional studyKimberly Turner, Andrea Carboni-Jiménez, Carla Benea, et al.
American Journal of Public Health|November 8, 2023
Health Effects of High-Concentration Cannabis Products: Scoping Review and Evidence MapLisa Bero, Rosa Lawrence, Jean-Pierre Oberste, et al.
Journal of Clinical Epidemiology|January 26, 2015
World Health Organization strong recommendations based on low-quality evidence (study quality) are frequent and often inconsistent with GRADE guidancePaul E Alexander, Juan P Brito, Ignacio Neumann, et al.
Environment International|May 9, 2016
Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosanPaula I Johnson, Erica Koustas, Hanna M Vesterinen, et al.
BMJ (Clinical Research Ed.)|October 14, 2021
Conduct and reporting of formula milk trials: systematic reviewBartosz Helfer, Jo Leonardi-Bee, Alexandra Mundell, et al.
Annals of Internal Medicine|July 15, 2024
Development and Evaluation of a Framework for Identifying and Addressing Spin for Harms in Systematic Reviews of InterventionsRiaz Qureshi, Kevin Naaman, Nicolas G Quan, et al.
Journal of Clinical Epidemiology|September 25, 2015
A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidancePaul E Alexander, Michael R Gionfriddo, Shelly-Anne Li, et al.
The Cochrane Database of Systematic Reviews|December 7, 2019
Cochrane Sustainable Healthcare: evidence for action on too much medicineMinna Johansson, Lisa Bero, Xavier Bonfill, et al.
BMJ (Clinical Research Ed.)|December 5, 2019
Pathways to independence: towards producing and using trustworthy evidenceRay Moynihan, Lisa Bero, Sue Hill, et al.
Pageof 21